⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OGN News
Organon & Co.
オルガノン、JADA ®®システムのラボリーへの売却を完了
businesswire.com
OGN
Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026
businesswire.com
OGN
Organon Completes Divestiture of JADA ® System to Laborie
businesswire.com
OGN
Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON ® (etonogestrel implant) 68 mg Radiopaque
businesswire.com
OGN
Organon conclut un accord de commercialisation pour Nilemdo ® de Daiichi Sankyo en France, au Danemark, en Islande, en Suède, en Finlande et en Norvège
businesswire.com
OGN
Organon sluit een akkoord voor de commercialisering van Daiichi Sankyo’s Nilemdo ® in Frankrijk, Denemarken, IJsland, Zweden, Finland en Noorwegen
businesswire.com
OGN
Organon sottoscrive un accordo di commercializzazione relativo a Nilemdo ® di Daiichi Sankyo in Francia, Danimarca, Islanda, Svezia, Finlandia e Norvegia
businesswire.com
OGN
Organon firma un acuerdo de comercialización para Nilemdo ® de Daiichi Sankyo en Francia, Dinamarca, Islandia, Suecia, Finlandia y Noruega
businesswire.com
OGN
Organon schließt Vermarktungsvereinbarung für Nilemdo ® von Daiichi Sankyo in Frankreich, Dänemark, Island, Schweden, Finnland und Norwegen
businesswire.com
OGN
Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo ® in France, Denmark, Iceland, Sweden, Finland and Norway
businesswire.com
OGN